XTX Topco Ltd bought a new position in shares of Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 10,573 shares of the business services provider's stock, valued at approximately $454,000.
Other large investors also recently made changes to their positions in the company. HighTower Advisors LLC acquired a new position in shares of Genpact in the 3rd quarter valued at approximately $232,000. Stifel Financial Corp bought a new stake in shares of Genpact in the 3rd quarter worth about $1,197,000. MML Investors Services LLC raised its stake in shares of Genpact by 31.4% in the 3rd quarter. MML Investors Services LLC now owns 12,058 shares of the business services provider's stock valued at $473,000 after purchasing an additional 2,879 shares in the last quarter. Sanctuary Advisors LLC lifted its position in shares of Genpact by 52.9% during the third quarter. Sanctuary Advisors LLC now owns 16,573 shares of the business services provider's stock worth $650,000 after purchasing an additional 5,734 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in Genpact by 6.5% in the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider's stock worth $162,318,000 after purchasing an additional 252,674 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Genpact Price Performance
Shares of NYSE:G traded up $0.25 on Friday, reaching $48.07. 496,958 shares of the company traded hands, compared to its average volume of 1,343,680. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock has a market capitalization of $8.44 billion, a PE ratio of 16.93, a P/E/G ratio of 1.84 and a beta of 1.06. The company's 50 day moving average is $49.90 and its 200-day moving average is $46.25. Genpact Limited has a fifty-two week low of $30.38 and a fifty-two week high of $56.76.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.41%. This is a boost from Genpact's previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. Genpact's payout ratio is presently 23.94%.
Insider Activity
In other news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 2.80% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have commented on G shares. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Needham & Company LLC raised their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Mizuho upped their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $50.38.
View Our Latest Report on G
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.